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Migration has contributed to the emergence of certain 
infectious diseases. To determine which infectious diseas-
es were most common among 2 mobile immigrant groups 
(sub-Saharan Africans and Latin Americans) in Spain, we 
analyzed health and demographic characteristics of 2,198 
immigrants referred to the Tropical Medicine Unit of Ramón 
y Cajal Hospital over a 20-year period. The most frequent di-
agnoses were for latent tuberculosis (716 patients [32.6%]), 
ﬁ   lariasis (421 [19.2%]), hepatropic virus chronic infection 
(262 [19.2%]), intestinal parasites (242 [11.0%]), and ma-
laria (212 [9.6%]). Health screening of immigrant popula-
tions is needed to ensure early diagnosis and treatment of 
potentially transmissible infections.
M
igration to the European Union has increased ex-
ponentially during the past 2 decades, with 1.9 
million new registered immigrants in 2008 alone (1). Of 
these, 700,000 arrived in Spain, currently the main recipi-
ent country in Europe. The number of documented im-
migrants in Spain increased from 0.5 million in 1995 to 
5.2 million on January 1, 2008, representing 11.3% of the 
country’s total population (2). Thus, Spain may be repre-
sentative of the impact of migration on certain emerging 
infectious diseases.
In mobile populations, characteristics and time of ac-
quisition of infections depend on exposure in the original 
country, during migration, and in the resettlement environ-
ment, leading to considerable heterogeneity in presentation. 
With a few exceptions (e.g., American trypanosomiasis), 
most tropical infections present no transmission risk for the 
host population (3). However, other infections that affect 
immigrants and are not exclusive to tropical areas, such 
as tuberculosis (TB) and HIV, can be transmitted (4). Be-
cause infections can be introduced in previously unexposed 
populations and incidence of preexisting infections highly 
prevalent in countries of origin may increase, the impact of 
mobile populations on public health should be addressed.
This article compares the characteristics and relevance 
of infectious diseases in 2 mobile immigrant groups in 
Spain: sub-Saharan Africans and Latin Americans. Two 
aims of the study were to improve awareness among clini-
cians of emerging infections associated with human mobil-
ity and to provide additional information about imported 
diseases. Appropriate medical management also would be 
expected to affect public health.
Methods
Study Population
The Tropical Medicine Unit (TMU) is a referral center 
at the infectious diseases department of the Ramón y Cajal 
Hospital in Madrid, Spain. In parallel with clinical work, 
we collected data about Latin American and sub-Saharan 
African immigrants seeking health care at TMU from April 
1989 through June 2008 and conducted an epidemiologic 
and clinical study. We excluded from the study immigrants 
classiﬁ  ed as visiting friends and relatives, patients lost to 
follow-up, and patients with incomplete tests as of June 
2008.
In Spain, basic health coverage is universal, and pa-
tients need only to possess a health card. Immigrants can 
acquire this card regardless of their residency status (legal 
or illegal). If cultural or linguistic differences make ob-
taining a health card difﬁ  cult, immigrants can be referred 
by nongovernmental organizations (NGOs). Patients are 
therefore referred from primary caregivers, specialists, or 
NGOs, or they can seek medical care on their own initiative 
(because of symptoms or to request a health examination). 
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Most immigrants seen at our unit have migrated for social 
or economic reasons and are from outside the European 
Union, primarily Latin America and sub-Saharan Africa.
Diagnoses
Demographic variables included age, sex, country of 
origin, health coverage (deﬁ   ned as holding Spain’s na-
tional health card), and preconsultation period (deﬁ  ned as 
months from arrival in Spain to ﬁ  rst consultation at TMU). 
We grouped patients’ primary reasons for seeking medi-
cal assistance at TMU into 10 syndromes: dermatologic, 
febrile, gastrointestinal, respiratory, genitourinary, neuro-
logic, musculoskeletal, hematologic–anemia, hematolog-
ic–eosinophilia, and asymptomatic. Each patient could be 
assigned to >1 of these categories.
Screening for asymptomatic patients comprised blood 
count, biochemistry, basic urinalysis, HIV serologic analy-
sis, hepatitis B virus (HBV) and HCV serologic analysis, 
rapid plasma reagin, Mantoux skin test, stool parasites, 
PCR for malaria in sub-Saharan Africans (since 2005), and 
Chagas disease serologic analysis (immunoﬂ  uorescent an-
tibody test, ELISA) and PCR (since 2003) in persons from 
Latin America. Infectious diseases were diagnosed follow-
ing standard techniques and grouped into 4 categories.
The  ﬁ   rst category was tropical infectious diseases, 
which were infections typically imported from tropical ar-
eas into Spain, even though some may be distributed world-
wide. Examples include ﬁ  lariasis, malaria, trypanosomia-
sis, cysticercosis, schistosomiasis, and intestinal parasites.
The second category was transmissible infectious dis-
eases, which were infections distributed globally but more 
prevalent in the countries of origin, with a high risk for 
transmission in the host country and that comprise a sub-
stantial proportion of cases in Spain. Examples include la-
tent and active TB, acute and chronic infections with hepa-
totropic virus, sexually transmitted infections (STI), HIV 
infection, and leprosy.
The third category was common infectious diseases, 
which were infections distributed worldwide and preva-
lent in tropical and nontropical areas but which are not the 
focus of this study. Examples include respiratory tract in-
fections, gastrointestinal bacterial infections, and urinary 
tract infections.
The fourth category was infrequent infectious diseas-
es, which were infections with <10 cases per diagnosis. Ex-
amples include toxoplasmosis, amebic liver abcesses, and 
leishmaniases. 
Statistical Analysis
We calculated frequency rates for reason for referral 
and infectious diagnoses for Latin Americans and sub-
Saharan Africans. Qualitative variables were compared us-
ing the χ2 test, the Fisher exact test, or the χ2 test for linear 
trends when necessary. For quantitative variables, the Stu-
dent t test for nonpaired variables or the Mann-Whitney 
U test were used. Signiﬁ  cance was designated at p<0.05. 
All tests were performed with the SPSS 15 software for 
Windows (SPSS Inc., Chicago, IL, USA).
Results
Demographic characteristics of the study population 
are shown in Table 1. The most frequent countries of ori-
gin for sub-Saharan African immigrants were Equatorial 
Guinea (35.7%), Nigeria (13.3%), Senegal (7.4%), and 
Cameroon (6.2%); for Latin Americans, they were Ecua-
dor (34.9%), Bolivia (27.8%), Peru (11.2%), and Colombia 
(8.8%).
During the 20-year study period, the number of pa-
tients seen increased signiﬁ  cantly (β = 10, p<0.001), as did 
the proportion of men and the proportion of Latin American 
immigrants. Three other variables (preconsultation period, 
age, and health coverage) did not differ signiﬁ  cantly. Table 
2 shows frequencies for each reason for seeking medical 
assistance according to areas of origin and grouped in 10 
syndromes.
For 2,088 (95.0%) of the 2,198 patients a ﬁ  nal diagno-
sis of infectious or noninfectious diseases was made; 110 
(5.3%) had no evidence of illness. Of patients who received 
>1 diagnosis. 1,377 (65.9%) had multiple diagnoses (>10/
patient): 34.1%, 28.9%, 17.8%, 10.1%, and 4.5% had 1, 2, 
3, 4, and 5 diagnoses, respectively. Among those classiﬁ  ed 
as asymptomatic at ﬁ  rst consultation, 87.8% had evidence 
of chronic disease (e.g., hypertension, diabetes, hypercho-
lesterolemia, iron deﬁ  ciency anemia, hemoglobinopathies, 
thyroid disease) or various infections (Tables 2–4).
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Table 1. Demographic characteristics of immigrant population seeking care at the Tropical Medicine Unit, Ramón y Cajal Hospital,
Madrid, Spain, 1989–2008* 
Characteristic Total Sub-Saharan Africans  Latin Americans  p value 
Study participants, no. (%)  2,198 (100)  1,564 (71.2)  634 (28.8) 
Male sex, no. (%)  1,303 (59.3)  882 (56.4)  421(66.4)  <0.001
Median age, y (IQR)  29 (22–36)  28 (22–35)  32 (24–40) 
Median preconsultation period, mo†  7 5 19 <0.001
Health coverage,‡ no. (%)  739 (33.6)  348 (22.3)  391(61.7)  <0.001
*IQR, interquartile range (25th–75th percentile). 
†Defined as months elapsed from arrival to Spain to first consultation at the Tropical Medicine Unit. 
‡Defined as holding Spain’s national health card.Diseases in Mobile Populations, Spain
Tropical Infectious Diseases
Filariasis
We found 421 ﬁ  lariasis cases, of which most occurred 
in sub-Saharan Africans. Of these, 258 were Onchocerca 
volvulus infections, 124 were Mansonella perstans infec-
tions, 29 were Loa loa infections, and 7 were M. strepto-
cerca infections. Three cases in Latin American patients 
were caused by O. volvulus infections.
Intestinal Parasites
Intestinal parasites were diagnosed in 242 patients, 
mostly from sub-Saharan Africa. The most frequent para-
sites identiﬁ  ed  were  Ascaris lumbricoides (35.5%) and 
Giardia intestinalis (28.5%).
Malaria
Malaria, diagnosed in 212 patients, occurred signiﬁ  -
cantly more often in sub-Saharan Africans than in Latin 
Americans. The median preconsultation period was 2 
months. Fifteen (7.1%) patients were asymptomatic when 
their malaria was diagnosed. Among the 199 sub-Saharan 
African malaria patients, 125 were infected with Plasmo-
dium falciparum, 13 with P. malariae, 10 with P. ovale, 
4 with P. vivax, 8 with mixed infections (5 with P. falci-
parum and P. malariae, 2 with P. falciparum and P. ovale, 
and 1 with P. malariae and P. ovale), and 39 with Plasmo-
dium sp. where speciﬁ  c species could not be determined, 
generally because the diagnosis was made when PCR was 
not available. Malaria was diagnosed in 13 Latin American 
patients; 10 had P. vivax infections and 3 had P. falciparum 
infections.
Chagas Disease
Of the 101 cases of Chagas disease diagnosed, all were 
in Latin American patients, with 95.0% from Bolivia, and 
most cases (71.3%) occurred in men. Of Chagas disease 
cases, 42.6% were asymptomatic and were detected after 
routine screening. Organ involvement was found in 20.7% 
of patients; 17.5% had cardiac disease, 2.0% had gastroin-
testinal involvement, and 1.2% had both.
Transmissible Infectious Diseases
Tuberculosis
Latent TB infection (716 cases) occurred signiﬁ  cant-
ly more often in sub-Saharan African than Latin Ameri-
can patients. Active TB (107 cases) occurred more often 
among Latin Americans; the highest proportions of patients 
were from Ecuador (21.4%) and Peru (17.5%). The median 
preconsultation period was 12 months. Of active TB cases, 
75 (70.1%) were pulmonary TB and 32 (30%) were extra-
pulmonary TB. Co-infection with HIV and active TB was 
detected in 12 (11.2%) patients, mostly from sub-Saharan 
Africa (75.0%).
Hepatitis
A total of 262 patients had chronic infection with hep-
atitis viruses. The prevalence was higher in sub-Saharan 
Africans. The most frequently identiﬁ  ed chronic hepatitis 
virus was HBV (60.7%). The prevalence of hepatitis B sur-
face antigen in sub-Saharan African patients was 9.8%. The 
prevalence of coinfection with HBV and HCV was 1.6%, 
and 0.9% with HBV and hepatitis D virus. Acute hepati-
tis infection was diagnosed infrequently: 41 (1.4%) cases, 
with no signiﬁ  cant differences between the 2 groups. In ad-
dition, 797 patients had evidence of past HBV infection, of 
whom 277 (34.7%) had antibody to virus core or virus core 
protein; 95.7% were from sub-Saharan Africa.
Sexually Transmitted Infections and HIV
STIs were found in 112 patients, mainly from sub-
Saharan Africa. Sixty-seven patients had latent syphilis, 
17 had bacterial vaginosis, 12 had trichomoniasis, 9 had 
genital herpes, 4 had Chlamydia trachomatis infections, 
and 3 had gonococcal urethritis. Among patients in whom 
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Table 2. Immigrants’ reasons for seeking medical assistance, by area of origin, Tropical Medicine Unit, Ramón y Cajal Hospital,
Madrid, Spain, 1989–2008* 
Syndrome 
Total population, no. (%), 
N = 2,198 
Sub-Saharan Africans, no. (%), 
n = 1,564 
Latin Americans, no. (%), 
n = 634  p value 
Hematologic–eosinophilia  570 (26)  435 (28)  135 (21.3)  0.002
Dermatologic 544 (24.7)  477 (30.5)  67 (10.6)  0.001
Fever 451 (20.5)  351 (22.4)  100 (15.8)  0.001
Asymptomatic  396 (18)  268 (17.1)  128 (20.2)  0.09
Gastrointestinal 363 (16.5)  269 (17.2)  94 (14.8)  0.608
Respiratory  314 (14.3)  209 (13.4)  105 (16.6)  0.006
Hematologic–anemia  283 (12.9)  230 (14.7)  53 (8.4)  0.001
Genitourinary  234 (10.6)  198 (12.7)  36 (5.7)  0.001
Neurologic 219 (10)  144 (9.2)  75 (11.8)  0.03
Musculoskeletal 169 (7.7)  141 (9)  28 (4.4)  0.001
*Because each patient could have >1 main reason for seeking medical assistance, the number of cases can be higher than the number of patients. 
Percentages were calculated as number of cases divided by number of patients in each group (total population, sub-Sahara African immigrants, or Latin 
American immigrants). RESEARCH
syphilis was diagnosed, 59 (88.0%) were from sub-Saharan 
Africa and 8 (11.9%) were from Latin America, 36 (53.7%) 
were men, and 10 (15%) were co-infected with HIV. Six 
were asymptomatic when they sought care at TMU. HIV 
was diagnosed in 97 patients; 19 were asymptomatic and 
82 (84.5%) were from sub-Saharan Africa.
Infrequent Infections
Nine patients had toxoplasmosis, 8 had amebic liver 
abscesses; 5 had rickettsiosis; 4 had Fasciola hepatica in-
fections; 2 each had cutaneous leishmaniasis, mucocutane-
ous leishmaniasis, and brucellosis; and 1 each had visceral 
leishmaniasis, hydatid disease, borreliosis, and human 
T-lymphotrophic virus type 1 infection. These infrequent 
infections occurred proportionally more frequently among 
Latin American than among sub-Saharan African patients.
Discussion
The large size of the population analyzed and the long 
time period (≈20 years) add strength to the study. Because 
one third of the study population were considered illegal 
aliens and lacked health insurance, our analysis was able to 
provide valuable information about infections affecting a 
group that is frequently not adequately represented in pub-
lished studies because of the usual restrictions on access to 
health services. Nonetheless, this study is subject to several 
limitations. 
In Spain, most immigrants come from a European 
Union member state (Romania, 14% of all immigrants in 
Spain), followed by northern Africa (Morocco, 12%) and 
Latin America (Ecuador, 8%) (2). Extrapolation of the re-
sults of this study to the global immigrant population may 
therefore be limited. However, these mobile groups are im-
portant because of the spectrum of imported diseases repre-
sented. This applies both to tropical diseases and transmis-
sible infections (5).
Comparison based on geographic distribution may 
exclude other important aspects involved in the develop-
ment of certain infectious diseases: socioeconomic status 
of the country, public health infrastructure, rural or urban 
origin, or reason for migration. However, characteristics 
of most immigrants seen at TMU were similar: most came 
from tropical, underdeveloped areas of Latin America 
and sub-Saharan Africa, and most migrated for economic 
reasons.
During the 20 years of data collection, diagnostic 
methods and screening procedures changed, thus inﬂ  uenc-
ing results over time. Depending on how the patients were 
referred to our clinic the frequency of the various diseases 
reported cannot be interpreted as prevalence rates in the 2 
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Table 3. Disease diagnoses in immigrants, by area of origin, Tropical Medicine Unit, Ramón y Cajal Hospital, Madrid, Spain, 1989–
2008*
Diagnostic category and disease 
Total population,  
no. (%), N = 2,198 
Sub-Saharan Africans,  
no. (%), n = 1,564 
Latin Americans,
no. (%), n = 634  p value 
Tropical infectious diseases 
  Filariasis  421 (19.2)  418 (26.7)  3 (0.4)  0.001
  Intestinal parasites  242 (11.0)  162 (10.4)  80 (12.6)  0.15
  Malaria  212 (9.6)  199 (12.7)  13 (2.1)  0.001
  Chagas disease  101 (4.5)  0 101 (15.9) 
  Schistosomiasis  39 (1.8)  38 (2.4)  1 (0.2)  0.001
  Cysticercosis  31 (1.4)  3 (0.2)  28 (4.4 )  0.001
Transmissible infectious diseases 
  Latent tuberculosis  716 (32.6)  596 (61.2)  120 (18.9)  0.001
  Active tuberculosis  107 (4.8)  52 (3.3)  55 (8.7)  0.001
  Hepatotropic virus, acute infection†  31 (1.4)  27 (1.7)  4 (0.6)  0.075
  Hepatotropic virus, chronic infection‡  262 (11.9)  257 (16.4)  10 (1.6)  0.001
  Sexually transmitted infections§  107 (4.9)  92 (5.9)  15 (2.4)  0.002
  HIV infection  97 (4.4)  82 (5.2)  15 (2.4)  0.005
  Leprosy  8 (0.4)  3 (0.2)  5 (0.8)  0.02
Common infectious diseases 
  Respiratory infections  61 (2.8)  36 (2.3)  25 (3.9)  0.013
  Gastrointestinal bacterial infections  92 (4.2)  69 (4.4)  23 (3.6)  0.705
  Urinary infections  69 (3.1)  45 (2.9)  24 (3.8)  0.135
  Skin infections  80 (3.6)  71 (4.5)  9 (1.4)  0.001
Infrequent infections  36 (1.7 )  20 (1.3)  16 (2.5)  0.025
Noninfectious diseases  596 (27.1)  430 (27.5)  166 (26.2)  0.978
*Because each patient could have >1 diagnosis, the number of cases can be higher than the number of patients. Percentages have been calculated as 
number of cases divided by number of patients in each group (total population, sub-Sahara African immigrants, or, Latin American immigrants). 
†Acute infections with hepatotropic virus caused by hepatitis A virus, hepatitis B virus, hepatitis E virus, cytomegalovirus, and Epstein-Barr virus  
‡Chronic infections with hepatotropic virus were caused by hepatitis B virus, hepatitis C virus, and hepatitis D virus. 
§Sexually transmitted infections comprised syphilis, bacterial vaginosis, trichomoniasis, gonococcal urethritis, Chlamydia trachomatis, and genital herpes 
virus.  Diseases in Mobile Populations, Spain
migrant populations considered. Because most individuals 
were referred for investigation of symptoms or diseases, 
the frequency observed can be expected to be higher than 
in the overall migrant population.
Demographic variables of age and sex are in accor-
dance with national data on immigrant populations (2) 
and are similar to other series (6,7), except for the larger 
proportion of males in the Latin American group. The sig-
niﬁ  cant difference in the preconsultation periods of the 2 
groups might be explained by the larger proportion of Latin 
Americans who held health cards and thus were seen ini-
tially by general practitioners. Because most sub-Saharan 
African immigrants were undocumented and referred from 
NGOs, TMU was their ﬁ  rst contact with the public health 
system. Nevertheless, the proportion of Latin Americans 
seen at TMU as a result of active health promotion cam-
paigns and screening for Chagas disease increased.
Consistent with other series (8), the most frequent rea-
sons for seeking medical assistance at TMU were hema-
tologic–eosinophilia, dermatologic syndrome, and fever. 
All syndromes occurred signiﬁ  cantly more often in sub-
Saharan Africans, except for respiratory and neurologic. 
Geographic variation in disease distribution would explain 
certain differences. The increased frequency of dermato-
logic syndrome and eosinophilia in Africans could be due 
to the greater incidence of ﬁ  lariasis; anemia could result 
from nutritional deﬁ   ciencies and hemoglobinopathies; 
and fever could be due to malaria. For Latin Americans, 
increased prevalence of neurocysticercosis and TB might 
explain the increased frequency of neurologic and respira-
tory syndromes.
The most common tropical disease was ﬁ  lariasis, 
with onchocerciasis the most frequent ﬁ  larial infection, af-
fecting sub-Saharans signiﬁ  cantly more often than Latin 
Americans. More than 99% of symptomatic onchocerciasis 
occurs in western sub-Saharan Africa, where most of the 
patients in the study originated. The number of cases diag-
nosed at TMU, however, has progressively decreased since 
2000. Screening for ﬁ  lariasis by microﬁ  laremia detection 
and skin snips should probably be considered in patients 
presenting pruritus or eosinophilia (9).
In Europe, as in Spain, immigrants account for ap-
proximately 50% of malaria cases (10). In our series, as in 
other national (11) and international (12) studies, most ma-
laria patients were from sub-Saharan Africa, and the most 
commonly isolated species was P. falciparum. However, P. 
vivax was the principal species diagnosed in Latin Ameri-
cans. A considerable number of patients were asymptom-
atic at diagnosis, probably because of partial immunity 
developed during residence in areas to which malaria is en-
demic (13) and the implementation of PCR for Plasmodi-
um spp. as a screening test in sub-Saharan Africans, which 
enables detection of very low parasitemia. Malaria screen-
ing should be considered in newly arrived immigrants from 
areas to which it is endemic, regardless of clinical presenta-
tion (14,15); in specialized referral centers, such as TMU, 
PCR with its higher sensitivity and speciﬁ  city should be 
available.
Migration is changing the geographic distribution of 
Chagas disease, which until recently has been limited to 
Latin America. During the 1970s, the United States was the 
leading recipient of Latin American migrants but Europe 
(especially Spain) is now a main recipient (16). A recent 
study in Spain estimated the number of immigrants poten-
tially infected with Trypanosoma cruzi could range from 
37,000 to 122,000 (17). Alternate, nonvectorial, routes 
of transmission (vertical or through blood transfusion or 
organ transplantation) and reactivation episodes in inmu-
nosuppressed persons make Chagas disease an emerging 
and potentially transmissible disease in the autochthonous 
population, and thus an important public health concern 
(18). Furthermore, severe cardiac disease could develop in 
infected persons; a broader knowledge of this aspect of the 
disease by clinicians is necessary. In our series, prevalence 
reached nearly 16% among Latin Americans. Bolivian pa-
tients accounted for 95% of cases, reﬂ  ecting its high en-
demicity (19). Electrocardiographic and echocardiographic 
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Table 4. Infectious diseases diagnoses in asymptomatic patients, 
Tropical Medicine Unit, Ramón y Cajal Hospital, Madrid, Spain, 
1989–2008
Diagnostic category and disease 
Asymptomatic cases, 
no. (%), n = 396 
Tropical infectious diseases 
 Filariasis  36  (9.1) 
  Intestinal parasites  35 (8.8) 
 Malaria  15  (3.8) 
  Chagas disease  43 (10.9) 
 Schistosomiasis  5  (1.3) 
 Cysticercosis  0
Transmissible infectious diseases 
  Latent tuberculosis  160 (40.4) 
  Active tuberculosis  3 (0.7) 
  Hepatotropic virus, acute infection*  2 (0.5) 
  Hepatotropic virus, chronic infection†  40 (10.1) 
  Sexually transmitted infections‡  10 (2.5) 
  HIV infection  19 (4.8) 
 Leprosy  0
Common infectious diseases 
 Respiratory  tract  infections  0
  Gastrointestinal bacterial infections  10 (2.5) 
  Urinary tract infections  9 (2.3) 
  Skin infections  9 (2.3) 
Infrequent infections  8 (2.0) 
*Acute infections with hepatotropic virus caused by hepatitis A virus, hepatitis 
B virus, hepatitis E virus, cytomegalovirus, and Epstein-Barr virus.  
†Chronic infections with hepatotropic virus were caused by hepatitis B 
virus, hepatitis C virus, and hepatitis D virus. 
‡Sexually transmitted infections comprised syphilis, bacterial vaginosis, 
trichomoniasis, gonococcal urethritis, Chlamydia trachomatis, and genital 
herpes virus.   RESEARCH
disorders were found in 15.9% and 7.3% of patients, re-
spectively. These results suggest that all immigrants from 
areas to which it is endemic should be screened.
In the literature, the prevalence of intestinal parasites 
in immigrants ranges from 11% to 67%, depending on the 
origin and type of immigrant, with higher frequencies in re-
cently arrived refugees and sub-Saharan Africans (7,20,21). 
However, we found a low prevalence (11%). The impact 
of intestinal parasitism is low because a considerable pro-
portion of affected persons are asymptomatic, and illness 
is generally low, with certain parasites (e.g., Strongy-
loides  stercoralis) (22). In our study, 11.5% of patients 
had no symptoms. These ﬁ  ndings question the usefulness 
of screening the migrant population from areas to which it 
is endemic for intestinal parasitism. Some authors propose 
empiric treatment with albendazole (23), effective against S. 
stercoralis and G. intestinalis (24), as the most cost-effec-
tive measure. Others argue against this measure for reasons 
such as potential side effects, possible incorrect treatment 
of certain pathogens (e.g., Entamoeba histolytica), and the 
inherent risks of treating a patient with neurocysticercosis. 
Although further studies are necessary to assess advantages 
and risks of empiric treatment over screening (15) as a pub-
lic health measure, an alternative approach could be selec-
tive screening of high-risk groups, such as pregnant women, 
children, and inmunosuppressed patients.
TB is an example of an infectious disease that has 
emerged with the increase in mobile populations (25). Prev-
alence of active TB among immigrants is higher than in the 
host population. We found active TB more often in Latin 
Americans than in sub-Saharan Africans, similar to other 
national studies (26). That TB prevalence rates/100,000 
population are as high as 195 and 266 in Ecuador and Bo-
livia, respectively (World Health Organization data, 2006, 
http://apps.who.int/globalatlas/dataQuery/default.asp), the 
most common countries of origin of our Latin American 
group, might explain this result. Median interval from ar-
rival in Spain to presentation with TB was 2 years, which is 
consistent with previous studies showing a higher risk for 
TB during the ﬁ  rst 2–5 years of residence in the host coun-
try and where activation of latent TB infection seems to be 
a common cause of TB among immigrants (27). The rate 
of latent TB (32.6%) in our study was consistent with other 
series (7). Latent TB occurred more often in sub-Saharan 
Africans than in Latin Americans.
Public heath interventions for control of TB in the im-
migrant population are intensely debated. Many authors 
consider that interrupting the ongoing community TB 
transmission through detection and treatment of active TB 
and contact investigation is the best cost-effective strategy 
(28). However, current guidelines in certain countries rec-
ommend screening for latent TB in immigrants, especially 
those who entered the host country within the previous 5 
years (29,30). Screening policies for latent TB face several 
difﬁ  culties, and no consensus has been reached, the best 
screening method is under discussion (chest radiographs, 
intradermal tuberculin test [IDT]), IDT interpretation is 
ambiguous (3 cutoff points may be considered), the false-
positive rate is high because of BCG (Mycobacterium bo-
vis BCG) vaccination, and ensuring high rates of treatment 
completion for latent TB in the migrant population has 
proven difﬁ  cult (31). Nevertheless, with the implementa-
tion of new screening techniques (interferon gamma release 
assay) that are less affected by BCG vaccination (32) and 
use of culturally adapted programs to improve adherence 
to treatment, screening for latent TB followed by appropri-
ate treatment could be a successful strategy for global TB 
control in Western countries. Some studies support a better, 
cost-effective approach to TB using screening (33).
Chronic HBV infection is a major health problem in 
sub-Saharan Africa and Asia, where prevalence is >8% 
(34). The mortality rate from chronic infection is ≈25% be-
cause of complications (liver cirrhosis and hepatocellular 
carcinoma). The 9.8% prevalence in our study was similar 
to others (7,35). In developing countries, many infections 
are acquired during the perinatal period, and patients devel-
op long-term complications in early adulthood, whereas in 
developed countries, infection and complications occur lat-
er in life. Screening for HBV in sub-Sahara African immi-
grants would help detect chronic infections in young adults, 
allowing early treatment and monitoring for complications. 
This could also prompt contact screening, vaccination, and 
education as preventive measures (15). Finally, when an 
isolated core antibody pattern is detected, a relatively com-
mon serologic result in the sub-Saharan African population, 
PCR assessment for occult chronic infection for HBV DNA 
may be required, especially in HIV-positive patients (35).
STIs other than HIV and viral hepatitis were diagnosed 
in 4.8% of the total population studied. Most STIs were due 
to latent syphilis (60%), particularly in the Africans. This 
trend toward more bacterial STIs in certain groups, such 
as immigrants, is consistent with observations throughout 
Spain and Europe (36). Most STIs, particularly syphilis, can 
be easily misdiagnosed because they can run a mild or as-
ymptomatic course, but complications and sequelae can be 
severe. Moreover, syphilis can be easily transmitted from 
mother to child. Intervention programs for immigrants, 
particularly sub-Saharan Africans, with active screening 
and treatment for syphilis could reduce the prevalence and 
transmission of this infection in the community.
In December 2007, the Joint United Nations Pro-
gramme on HIV/AIDS (37) stated an estimated 33.2 million 
persons were living with HIV infection worldwide, with 
most (22.5 million) living in sub-Saharan Africa. In our se-
ries, HIV infection also occurred signiﬁ  cantly more often 
among sub-Saharan Africans than among Latin Americans. 
1750  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 11, November 2009Diseases in Mobile Populations, Spain
Throughout western Europe, HIV infection increasingly, 
and disproportionately, affects immigrants from countries 
in which the prevalence of HIV/AIDS is high and, in most 
countries, accounts for the majority of heterosexually ac-
quired HIV infections diagnosed in recent years (38). In 
some series, HIV is diagnosed in immigrants and refugees 
at a later stage of infection, with lower CD4 cell counts, a 
larger proportion of females, and with different HIV sub-
types (39). This highlights the need for screening immi-
grants, particularly sub-Saharans, for HIV to enable early 
diagnosis and treatment as well as prevention and educa-
tion. A larger social and cultural program support is neces-
sary to ensure adequate treatment as well as access to the 
health care system.
Increased population mobility has led to the disap-
pearance of existing barriers for the spread of certain dis-
eases. Characteristics of mobile populations are becoming 
increasingly heterogeneous (4). Epidemiologic studies in 
mobile groups help determine factors possibly associated 
with greater risk for certain pathologies and identify which 
of the latter may inﬂ  uence health to a greater extent. Our 
study may improve knowledge about pathology in 2 impor-
tant mobile populations in Spain, enabling early diagnosis 
and treatment of potentially transmissible infections (TB), 
education and prevention programs (STIs, HIV) and catch-
ing up on vaccination (40), with ensuing positive public 
health repercussions. Future research may focus on devel-
opment of diagnostic protocols for imported diseases on 
the basis of epidemiologic ﬁ  ndings.
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